• HLY78: A Causal Wnt Assay Design Guide

  2026-09-01

  HLY78 is a Wnt/β-catenin pathway modulator that enables ligand-dependent pathway interrogation. This guide connects its Axin–LRP6 mechanism with assay design, zebrafish development, and cautious fibrosis-model interpretation.

• Phosphatase Inhibitor Cocktail 1 for Cardiac Signaling

  2026-09-01

  Protect phosphorylation-dependent signaling while profiling UBA1–ATG5 regulation in cardiac hypertrophy models. This 100X DMSO formulation combines alkaline and serine/threonine phosphatase coverage for Western blotting, co-immunoprecipitation, pull-down assays, and phosphoproteomic workflows.

• Propidium Iodide: From Signal to Strategy

  2026-08-31

  A translational guide to using Propidium iodide as a mechanistic readout of membrane integrity, DNA content, and treatment response in oncology research.

• Cepharanthine: From Apoptosis to Translation

  2026-08-31

  Cepharanthine is a biscoclaurine alkaloid with a translationally attractive profile spanning apoptosis research, endometriosis models, cancer biology, and chemotherapy support. This article connects its mechanistic signals to practical model selection, evidence grading, formulation strategy, and the decisions required to move from promising preclinical data toward clinically relevant development.

• Streptavidin-FITC for Sialylation Adhesion Assays

  2026-08-30

  Streptavidin-FITC converts biotinylated probes, antibodies, and nucleic acids into a practical fluorescence readout for cell-surface glycosylation and bacterial adhesion studies. Its FITC signal supports microscopy, tissue staining, and flow cytometry workflows that can connect ST3GAL1-dependent sialylation with Fusobacterium nucleatum binding.

• Risedronate Sodium: Inhaled and Cellular Workflows

  2026-08-29

  Risedronate Sodium supports practical workflows spanning osteoclast assays, nano-enabled pulmonary delivery, and exploratory lung or tumor-cell studies. This guide connects FPPS inhibition with formulation QC, assay controls, and troubleshooting for more reproducible bone metabolism research.

• Ciclesonide (B3477) for Reliable Cell Assays

  2026-08-28

  Learn how Ciclesonide (SKU B3477) can improve interpretation of airway-cell viability, proliferation, and inflammation assays by accounting for prodrug activation, solvent compatibility, and glucocorticoid receptor potency. The guide also distinguishes established Ciclesonide pharmacology from emerging ERAD-hijacking research.

• H-89: cAMP-Dependent Protein Kinase Inhibitor

  2026-08-28

  H-89 is a cAMP-dependent protein kinase inhibitor used to test protein kinase A contributions to cAMP signaling, metabolism, proliferation, and apoptosis. Its reported 48 nM PKA IC50 supports biochemical pathway interrogation, but cellular conclusions require selectivity controls and orthogonal validation.

• DDX21–NAT10 Signaling in Colorectal Cancer Metastasis

  2026-08-27

  The reference study identifies a DDX21–SIRT7–NAT10 regulatory axis that connects RNA-binding protein competition with ac4C-dependent stabilization of metastasis- and angiogenesis-associated transcripts in colorectal cancer. Its combination of clinical profiling, cellular perturbation, and in vivo validation provides a mechanistic framework for interpreting DDX21 as a potential therapeutic target, while also clarifying why RNA stability can be as important as transcriptional output in tumor progression.

• Cediranib (AZD2171): From Pathway to Proof

  2026-08-27

  A translational framework for using Cediranib (AZD2171) to connect VEGFR biology, angiogenesis assays, response metrics, and preclinical decision-making.

• THZ1: Covalent CDK7 Inhibitor Workflows

  2026-08-26

  THZ1 combines potent, irreversible CDK7 inhibition with a practical workflow for connecting transcriptional disruption to growth arrest and apoptosis. This guide explains how to use it in T-ALL and broader cancer biology studies while avoiding solvent, timing, and cross-domain interpretation errors.

• T7 RNA Polymerase for CRISPR RNA Design

  2026-08-26

  T7 RNA Polymerase enables promoter-specific in vitro transcription for gRNA and other research RNAs. This guide focuses on a practical, evidence-informed framework for choosing plasmid or oligonucleotide templates and interpreting CRISPR editing assays.

• Cas9 mRNA, Nuclear Export, and Editing Precision

  2026-08-25

  A mechanistic and translational analysis of how Cap1-capped, m1Ψ-modified Cas9 mRNA can support controlled CRISPR-Cas9 genome editing, informed by evidence that nuclear mRNA export is an actionable regulator of editing precision.

• VX-661 and the Next Era of CFTR Precision

  2026-08-25

  VX-661 is more than a trafficking reagent: it is a lens into how folding, proteostasis, variant biology, and treatment sequence shape F508del CFTR rescue. This thought-leadership guide translates recent calnexin findings into practical strategy for rigorous cystic fibrosis research.

• TRPV1+ Nerves and the Somato-Autonomic Reflex

  2026-08-24

  Song et al. identify a neural circuit in which stimulation of TRPV1+ peripheral afferents at the nape activates coordinated brainstem, sympathetic, and vagal-adrenal pathways that suppress systemic inflammation. The study combines pharmacological stimulation, genetic controls, endocrine measurements, cytokine profiling, and splenic RNA sequencing to connect sensory input with peripheral immune regulation.

537 records 5/36 page Previous Next 12345 下5页 Last page